BioMarin Expands Again in Enzyme Replacement, Paying $70M for Long-Acting Fabry Drug
BioMarin positive factors rights to a Fabry illness enzyme substitute remedy with potential dosing benefits over merchandise from Sanofi and ...
Tag: Fabry
Sangamo’s Fabry therapy partner search looks futile, and Geoff Porges is back
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!